David Ellis Kellstein

Title: David Ellis Kellstein: Innovator in Pharmaceutical Compositions

Introduction

David Ellis Kellstein is a notable inventor based in Warren, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions for pain relief medications. His work focuses on creating effective and safe formulations that can be manufactured on a large scale.

Latest Patents

Kellstein holds a patent for an innovative ibuprofen and acetaminophen tablet. This invention provides novel compositions, methods of treatment, and methods of manufacture that are commercially viable. The unique characteristics and synergistic effects of the disclosed compositions demonstrate a product with optimal analgesia, anti-pyresis, and safety profiles. The methods of manufacturing described in the patent allow for large-scale production of this novel tablet, showcasing its potential for widespread use.

Career Highlights

Kellstein is currently associated with Haleon US Holdings LLC, where he continues to work on advancements in pharmaceutical formulations. His expertise in the field has led to the development of products that enhance patient care and treatment outcomes.

Collaborations

Throughout his career, Kellstein has collaborated with talented professionals, including Christine Drumheller Andrews and Kevin Scott Kinter. These collaborations have contributed to the success of his projects and the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

David Ellis Kellstein's contributions to the field of pharmaceuticals, particularly through his patent for ibuprofen and acetaminophen tablets, highlight his role as an innovator. His work not only improves pain management but also emphasizes the importance of safe and effective medication formulations.